Search - tctmd.com

Displaying 41 - 60 of 106

Sort: Relevancy | Date

News Conference News ESC 2018

COMMANDER HF: Low-Dose Rivaroxaban Flops in Heart Failure

Todd Neale

August 27, 2018

News Conference News ESC 2018

MITRA-FR: No Benefit of MitraClip in Functional MR

Shelley Wood

August 27, 2018

News Conference News ESC 2018

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

Todd Neale

August 26, 2018

News Conference News ESC 2018

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

Shelley Wood

August 25, 2018

News Conference News ESC 2018

CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients

Todd Neale

August 25, 2018

News Daily News

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

L.A. McKeown

August 20, 2018

News Opinion Fellow Talk

Three Lessons Learned in Using Myocardial Viability to Guide Multivessel Revascularization

Yashasvi Chugh, MD

August 16, 2018

News Daily News

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

L.A. McKeown

August 09, 2018

News Daily News

After Cardiotoxic Chemo, Less Than Half of Women With Breast Cancer Get Recommended Monitoring

Caitlin E. Cox

August 06, 2018

News Daily News

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

Caitlin E. Cox

July 30, 2018

News Daily News

Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock

L.A. McKeown

July 03, 2018

News Conference News The Structural Heart Disease Summit 2018

Hybrid Surgical/Interventional LV Reconstruction Improves Ejection Fraction and Patient Symptoms

Michael O'Riordan

June 27, 2018

News Conference News The Structural Heart Disease Summit 2018

Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions

Shelley Wood

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Case Examples: What Would You Do in These Recurrent MR Patients?

Presenter: Mayra Guerrero, Vinod H. Thourani, Hemal Gada, Isaac George, Jonathon A. Leipsic, Jeffrey J. Popma, Dee Dee Wang

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Clinical Management Alternatives in Patients With Recurrent MR (After Either Surgical or Transcatheter MV Repair)

Presenter: Mayra Guerrero, Vinod H. Thourani

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Optimal Surgical Technique to Prevent Recurrent MR After Mitral Valve Repair

Presenter: Mayra Guerrero, Vinod H. Thourani, David H. Adams

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case Examples: What Would You Do in These Narrow LVOT Patients?

Presenter: Mayra Guerrero, Vinod H. Thourani, Hemal Gada, Isaac George, Jonathon A. Leipsic, Jeffrey J. Popma, Dee Dee Wang

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Intra and Postprocedure Management of Narrowed LVOT After TMVR

Presenter: Mayra Guerrero, Vinod H. Thourani, Neil E. Moat

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Evolving CT Imaging Concepts on Measuring the Neo-LVOT After TMVR

Presenter: Mayra Guerrero, Vinod H. Thourani, Dee Dee Wang

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case Examples: What Would You Do in These MAC Patients?

Presenter: Mayra Guerrero, Vinod H. Thourani, Hemal Gada, Isaac George, Jonathon A. Leipsic, Jeffrey J. Popma, Dee Dee Wang

June 21, 2018

Advertisement

COMMANDER HF: Low-Dose Rivaroxaban Flops in Heart Failure

MITRA-FR: No Benefit of MitraClip in Functional MR

MARINER Fails to Meet Primary Endpoint Testing Rivaroxaban for Extended VTE Thromboprophylaxis

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

Three Lessons Learned in Using Myocardial Viability to Guide Multivessel Revascularization

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

After Cardiotoxic Chemo, Less Than Half of Women With Breast Cancer Get Recommended Monitoring

Do PVADs and IABPs Offer Similar Survival in High-Risk PCI or Cardiogenic Shock?

Norepinephrine Bests Epinephrine in Battle of the Vasopressors in Cardiogenic Shock

Hybrid Surgical/Interventional LV Reconstruction Improves Ejection Fraction and Patient Symptoms

Will Percutaneous Mitral Repair Catch Up or Surpass Surgery? Experts Make Their Predictions

Case Examples: What Would You Do in These Recurrent MR Patients?

Clinical Management Alternatives in Patients With Recurrent MR (After Either Surgical or Transcatheter MV Repair)

Optimal Surgical Technique to Prevent Recurrent MR After Mitral Valve Repair

Case Examples: What Would You Do in These Narrow LVOT Patients?

Intra and Postprocedure Management of Narrowed LVOT After TMVR

Evolving CT Imaging Concepts on Measuring the Neo-LVOT After TMVR

Case Examples: What Would You Do in These MAC Patients?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content